Epilepsy in later life
Martin J Brodie, Andrew T Elder, Patrick Kwan
The Lancet Neurology | ELSEVIER SCIENCE INC | Published : 2009
MJB is a consultant for Pfizer, UCB Pharma, Eisai, GlaxoSmithKline, Valeant, Johnson & Johnson, Schwarz Pharma, Sierra Neuropharmaceuticals, Ikano Therapeutics, and Medtronic. He has received research grants from Pfizer, UCB Pharma, and Eisai within the past 3 years. PK has received contracted research grants from Eisai, Johnson & Johnson, Pfizer, and UCB Pharma within the past 3 years. ATE has no conflicts of interest.